Healthcare provider profile · identity verified

Brooke Arledge Bostic, MD

Family Practice · RUCKERSVILLE, VA · NPI 1730121823

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	300	92
Atorvastatin Calcium	Atorvastatin Calcium	283	73
Losartan Potassium	Losartan Potassium	275	78
Omeprazole	Omeprazole	246	71
Amlodipine Besylate	Amlodipine Besylate	219	66
Rosuvastatin Calcium	Rosuvastatin Calcium	202	69
Furosemide	Furosemide	199	59
Metoprolol Succinate	Metoprolol Succinate	182	55
Hydrochlorothiazide	Hydrochlorothiazide	176	51
Lisinopril	Lisinopril	162	50
Sertraline Hcl	Sertraline Hcl	162	33
Eliquis	Apixaban	136	26
Metformin Hcl	Metformin Hcl	132	40
Tamsulosin Hcl	Tamsulosin Hcl	126	32
Albuterol Sulfate Hfa	Albuterol Sulfate	120	37
Glipizide Er	Glipizide	119	33
Famotidine	Famotidine	118	40
Quetiapine Fumarate	Quetiapine Fumarate	115	22
Gabapentin	Gabapentin	111	34
Pravastatin Sodium	Pravastatin Sodium	108	35
Trazodone Hcl	Trazodone Hcl	107	28
Fluoxetine Hcl	Fluoxetine Hcl	94	25
Prednisone	Prednisone	92	44
Montelukast Sodium	Montelukast Sodium	88	22
Ropinirole Hcl	Ropinirole Hcl	88	19
Tizanidine Hcl	Tizanidine Hcl	88	21
Metoprolol Tartrate	Metoprolol Tartrate	85	22
Allopurinol	Allopurinol	76	22
Simvastatin	Simvastatin	74	22
Meloxicam	Meloxicam	72	19
Pregabalin	Pregabalin	71	16
Bupropion Xl	Bupropion Hcl	70	18
Pantoprazole Sodium	Pantoprazole Sodium	68	20
Cephalexin	Cephalexin	67	45
Doxazosin Mesylate	Doxazosin Mesylate	65	20
Clonazepam	Clonazepam	64	20
Potassium Chloride	Potassium Chloride	63	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	58	33
Triamcinolone Acetonide	Triamcinolone Acetonide	56	26
Escitalopram Oxalate	Escitalopram Oxalate	55	15
Finasteride	Finasteride	50	suppressed
Ozempic	Semaglutide	50	16
Pioglitazone Hcl	Pioglitazone Hcl	50	15
Duloxetine Hcl	Duloxetine Hcl	48	suppressed
Carvedilol	Carvedilol	46	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	13
Donepezil Hcl	Donepezil Hcl	46	suppressed
Fluticasone Propionate	Fluticasone Propionate	46	15
Oxycodone Hcl	Oxycodone Hcl	45	suppressed
Azithromycin	Azithromycin	43	33
Buspirone Hcl	Buspirone Hcl	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	12
Spironolactone	Spironolactone	42	11
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Atenolol	Atenolol	39	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	11
Synthroid	Levothyroxine Sodium	39	14
Methenamine Hippurate	Methenamine Hippurate	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Risperidone	Risperidone	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Ondansetron Odt	Ondansetron	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Ramelteon	Ramelteon	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	22
Tramadol Hcl	Tramadol Hcl	30	suppressed
Olanzapine	Olanzapine	29	suppressed
Promethazine Hcl	Promethazine Hcl	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Haloperidol	Haloperidol	25	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Premarin	Estrogens, Conjugated	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Topiramate	Topiramate	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Divalproex Sodium Er	Divalproex Sodium	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Valsartan	Valsartan	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Baclofen	Baclofen	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Nadolol	Nadolol	17	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Glimepiride	Glimepiride	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Digoxin	Digoxin	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Penicillin V Potassium	Penicillin V Potassium	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error